EBMT 2019 | CAR T-cell therapy: what clinicians need to know about managing the AEs
David Maloney
• 26 Mar 2019
From the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany, David Maloney, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, talks about the adverse events associated with CAR T-cell therapy and what clinicians need to be aware of.
